ArticleThe oncologist2024

Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.

Thomas Stricker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.